Immunotherapies

You are here

Immunotherapies

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Lung Cancer Video Library - Spanish Language: PDL1 as a biomarker for second line treatment
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for second-line treatment.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies, Second-line treatment
Lung Cancer Video Library - Spanish Language: PDL1 as a biomarker for first line treatment
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for first-line treatment.
Cancer Journey:
Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Tumor Marker Tests, First-line treatment, Immunotherapies
Lung Cancer Video Library - Spanish Language: Combinations of first-line treatment, immunotherapy agents combined
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy combined.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies
Lung Cancer Video Library - Spanish Language: Combinations of first-line treatment, immunotherapy with chemotherapy
Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy with chemotherapy.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies
Lung Cancer Video Library 2017 - The Role for Immunotherapy in Patients with a Driver Mutation
Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses the role for immunotherapy in patients with a driver mutation.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies

Articles

No Result Found

Community Forum

No Result Found